Breast milk fatty acid composition and allergic disease in 1- and 4-year-olds

A. H. Wijga, H. A. Smit, H. C. Boshuizen, M. Kerkhof, B. Brunekreef (Bilthoven, Groningen, Utrecht, The Netherlands)

Source: Annual Congress 2004 - Paediatric respiratory epidemiology I
Session: Paediatric respiratory epidemiology I
Session type: Thematic Poster Session
Number: 1093
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. H. Wijga, H. A. Smit, H. C. Boshuizen, M. Kerkhof, B. Brunekreef (Bilthoven, Groningen, Utrecht, The Netherlands). Breast milk fatty acid composition and allergic disease in 1- and 4-year-olds. Eur Respir J 2004; 24: Suppl. 48, 1093

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The role of partially hydrolysed formulae, probiotics and omega-3 fatty acids in cow‘s milk allergy in children
Source: Annual Congress 2009 - Clinical advances in childhood asthma
Year: 2009

Food and fatty acid intake and atopic disease in adults
Source: Eur Respir J 2004; 23: 575-582
Year: 2004



The n-3 long chain polyunsaturated fatty acids (n-3LCPUFA) are inversely linked to asthma and persistent symptoms of allergy in children born to mothers with allergy
Source: Eur Respir J 2006; 28: Suppl. 50, 251s
Year: 2006

Content of omega-3 fatty acids partially explains the asthma-protective effect of unprocessed cow’s milk
Source: International Congress 2015 – Early life matters: prematurity and risk factors for asthma
Year: 2015


Late Breaking Abstract: Prenatal n-3, n-6, and trans fatty acids and the risk of eosinophilia and allergic sensitization in children at age 3 years
Source: Annual Congress 2010 - Paediatric asthma treatment and monitoring
Year: 2010



Glucocorticoids correct fatty acids composition in asthma patients. Composition of fatty acids in high density lipoproteins in bronchitis patients
Source: Eur Respir J 2007; 30: Suppl. 51, 145s
Year: 2007

Oral polyunsaturated fatty acid supplementation as adjuvant therapy for asthmatic children
Source: Annual Congress 2012 - Asthma treatment: efficacy and safety
Year: 2012

Intake of n-3 polyunsaturated fatty acids in childhood, FADS genotype and incident asthma
Source: Eur Respir J, 58 (3) 2003633; 10.1183/13993003.03633-2020
Year: 2021



Omega-3 polyunsaturated fatty acids and FADS genotype: is personalised prevention of asthma on the horizon?
Source: Eur Respir J, 58 (3) 2101386; 10.1183/13993003.01386-2021
Year: 2021



Prenatal exposure to n-6/n-3 fatty acids, trace elements and minerals and risk of atopic disease in childhood: birth cohort study
Source: Eur Respir J 2003; 22: Suppl. 45, 564s
Year: 2003

Is adult asthma/chronic bronchitis related to the intake of fat especially polyunsaturated ω-6 and ω-3 fatty acids?
Source: Eur Respir J 2001; 18: Suppl. 33, 199s
Year: 2001

Prenatal polyunsaturated fatty acid exposure is associated with childhood atopy and wheeze
Source: Annual Congress 2010 - Paediatric epidemiology
Year: 2010



Association between Ω3 and Ω6 fatty acid dietary intakes and serum inflammatory markers in Spanish COPD patients
Source: Annual Congress 2010 - The impact of genes and environment on obstructive airway diseases
Year: 2010


Polyunsaturated fatty acids in maternal diet and maternal and cord blood in relation to atopic dermatitis in children
Source: Eur Respir J 2004; 24: Suppl. 48, 161s
Year: 2004

Intake of antioxidants and n-3 and n-6 PUFA in relation to asthma and eczema in a cohort of pregnant women
Source: Eur Respir J 2002; 20: Suppl. 38, 428s
Year: 2002

Allergic sensitization and diet: ecological analysis in selected European cities
Source: Eur Respir J 2001; 17: 395-402
Year: 2001



Supplementation with omega-3 fatty acids and atopy symptoms in infants: a randomized controlled trial
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008


Dietary supplementation over one year with fatty acids reduces inflammatory markers and produces clinical improvement in adults with cystic fibrosis
Source: Annual Congress 2007 - Cystic fibrosis lung disease: what do we measure? What do we know?
Year: 2007


Polyunsaturated fatty acids, lactobacillus bifidus, vitamin A and D in the treatment of IgA immunodeficiency in children with frequent respiratory infections
Source: Eur Respir J 2004; 24: Suppl. 48, 357s
Year: 2004